Cardiovascular
1 drug is in development for Alagille Syndrome.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Alagille Syndrome pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| livmarli | Mirum Pharmaceuticals, Inc. (MIRM) |
About this indication
Alagille Syndrome context
Cardiovascular·MeSH: Alagille Syndrome (D016738)
Also known as: Alagilles Syndrome, Cholestasis with Peripheral Pulmonary Stenosis, Dysplasia, Arteriohepatic (AHD), Hepatic Ductular Hypoplasia, Syndromatic, Syndrome, Alagille Watson, Syndrome, Cardiovertebral, Syndrome, Hepatofacioneurocardiovertebral, Syndrome, Watson Alagille, Syndrome, Watson Miller
Frequently asked questions
How many drugs are in development for Alagille Syndrome?
BioSniper tracks 1 drug in development for Alagille Syndrome across 1 company.
How many clinical trials target Alagille Syndrome?
There are 5 clinical trials targeting Alagille Syndrome tracked by BioSniper.